Published in Nat Rev Nephrol on November 01, 2009
Rabbit antithymocyte globulin versus basiliximab in renal transplantation. N Engl J Med (2006) 4.79
Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients. J Am Soc Nephrol (2009) 2.08
Interleukin 2 receptor antagonists for renal transplant recipients: a meta-analysis of randomized trials. Transplantation (2004) 1.58
Efficacy of anti-IL-2 receptor antibodies compared to no induction and to antilymphocyte antibodies in renal transplantation. Am J Transplant (2007) 1.12
HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med (2008) 7.42
Rapamycin inhibits the growth and metastatic progression of non-small cell lung cancer. Clin Cancer Res (2004) 5.40
Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med (2005) 5.02
Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest (2010) 3.59
Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation (2005) 3.57
Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care (2012) 3.20
Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice. J Exp Med (2007) 2.86
Noninvasive diagnosis of BK virus nephritis by measurement of messenger RNA for BK virus VP1 in urine. Transplantation (2002) 2.86
MicroRNA expression profiles predictive of human renal allograft status. Proc Natl Acad Sci U S A (2009) 2.36
Dendritic cells with TGF-beta1 differentiate naive CD4+CD25- T cells into islet-protective Foxp3+ regulatory T cells. Proc Natl Acad Sci U S A (2007) 2.10
Rapamycin is an effective inhibitor of human renal cancer metastasis. Kidney Int (2003) 1.83
Comparison of laparoendoscopic single-site donor nephrectomy and conventional laparoscopic donor nephrectomy: donor and recipient outcomes. Urology (2011) 1.62
Gut microbial community structure and complications after kidney transplantation: a pilot study. Transplantation (2014) 1.60
Noninvasive prediction of organ graft rejection and outcome using gene expression patterns. Transplantation (2008) 1.50
Noninvasive detection of renal allograft inflammation by measurements of mRNA for IP-10 and CXCR3 in urine. Kidney Int (2004) 1.48
Successful transplantation of single kidneys from pediatric donors weighing less than or equal to 10 kg into standard weight adult recipients. Transplantation (2010) 1.39
Rapamycin blocks tumor progression: unlinking immunosuppression from antitumor efficacy. Transplantation (2002) 1.33
Tacrolimus enhances transforming growth factor-beta1 expression and promotes tumor progression. Transplantation (2003) 1.16
MicroRNAs: small RNAs with big effects. Transplantation (2010) 1.15
Angiogenic factors in superimposed preeclampsia: a longitudinal study of women with chronic hypertension during pregnancy. Hypertension (2012) 1.14
Systemic transforming growth factor-beta1 gene therapy induces Foxp3+ regulatory cells, restores self-tolerance, and facilitates regeneration of beta cell function in overtly diabetic nonobese diabetic mice. Transplantation (2005) 1.13
Hypertension, kidney disease, HIV and antiretroviral therapy among Tanzanian adults: a cross-sectional study. BMC Med (2014) 1.10
Hyperexpression of Foxp3 and IDO during acute rejection of islet allografts. Transplantation (2007) 1.08
Enhanced granulysin mRNA expression in urinary sediment in early and delayed acute renal allograft rejection. Transplantation (2004) 1.07
CD103 mRNA levels in urinary cells predict acute rejection of renal allografts. Transplantation (2003) 1.07
Mitochondrial targeting with antioxidant peptide SS-31 prevents mitochondrial depolarization, reduces islet cell apoptosis, increases islet cell yield, and improves posttransplantation function. J Am Soc Nephrol (2006) 1.05
Transforming growth factor beta and progression of renal disease. Kidney Int Suppl (2003) 1.04
MicroRNA sequence profiles of human kidney allografts with or without tubulointerstitial fibrosis. Transplantation (2012) 1.03
Transforming growth factor beta signaling, vascular remodeling, and hypertension. N Engl J Med (2006) 1.01
Validation of noninvasive diagnosis of BK virus nephropathy and identification of prognostic biomarkers. Transplantation (2010) 0.99
Discovery and validation of a molecular signature for the noninvasive diagnosis of human renal allograft fibrosis. Transplantation (2012) 0.98
Noninvasive diagnosis of acute rejection of renal allografts. Curr Opin Organ Transplant (2010) 0.98
Comparison of complications of laparoscopic versus laparoendoscopic single site donor nephrectomy using the modified Clavien grading system. J Urol (2011) 0.98
Serine proteinase inhibitor-9, an endogenous blocker of granzyme B/perforin lytic pathway, is hyperexpressed during acute rejection of renal allografts. Transplantation (2003) 0.96
Epidemiology of BK virus in renal allograft recipients: independent risk factors for BK virus replication. Transplantation (2008) 0.95
Measurement of apoptosis of intact human islets by confocal optical sectioning and stereologic analysis of YO-PRO-1-stained islets. Transplantation (2005) 0.94
Genomic biomarkers correlate with HLA-identical renal transplant tolerance. J Am Soc Nephrol (2013) 0.94
Proapoptotic Bax is hyperexpressed in isolated human islets compared with antiapoptotic Bcl-2. Transplantation (2002) 0.90
Urinary cell levels of mRNA for OX40, OX40L, PD-1, PD-L1, or PD-L2 and acute rejection of human renal allografts. Transplantation (2010) 0.90
Enforced c-REL deficiency prolongs survival of islet allografts1. Transplantation (2002) 0.89
Independent risk factors for urinary tract infection and for subsequent bacteremia or acute cellular rejection: a single-center report of 1166 kidney allograft recipients. Transplantation (2013) 0.88
Urinary cell mRNA profiles predictive of human kidney allograft status. Immunol Rev (2014) 0.88
Correlation between interleukin-15 and granzyme B expression and acute lung allograft rejection. Transpl Immunol (2004) 0.87
Circulating levels of 25-hydroxyvitamin D and acute cellular rejection in kidney allograft recipients. Transplantation (2014) 0.87
Early corticosteroid withdrawal in recipients of renal allografts: a single-center report of ethnically diverse recipients and recipients of marginal deceased-donor kidneys. Transplantation (2012) 0.85
Molecular signatures of urinary cells distinguish acute rejection of renal allografts from urinary tract infection. Transplantation (2003) 0.85
On the detection of anti-HLA antibodies using single antigen bead Luminex assay: lot-to-lot variations in MFI. Transplantation (2013) 0.85
Transcriptional profiling to assess the clinical status of kidney transplants. Nat Clin Pract Nephrol (2006) 0.85
Immunosuppressive drug therapy. Cold Spring Harb Perspect Med (2013) 0.83
Transforming growth factor beta and excess burden of renal disease. Trans Am Clin Climatol Assoc (2009) 0.82
Diannexin decreases inflammatory cell infiltration into the islet graft, reduces β-cell apoptosis, and improves early graft function. Transplantation (2010) 0.82
Dendritic cells with TGF-β1 and IL-2 differentiate naive CD4+ T cells into alloantigen-specific and allograft protective Foxp3+ regulatory T cells. Transplantation (2012) 0.81
Noninvasive diagnosis of acute rejection of solid organ transplants. Front Biosci (2004) 0.81
Noninvasive prognostication of polyomavirus BK virus-associated nephropathy. Transplantation (2013) 0.80
The natural history, risk factors and outcomes of polyomavirus BK-associated nephropathy after renal transplantation. Nat Clin Pract Nephrol (2006) 0.78
Concurrent acute cellular rejection is an independent risk factor for renal allograft failure in patients with C4d-positive antibody-mediated rejection. Transplantation (2012) 0.78
HLA identical non-chimeric and HLA disparate chimeric renal transplant tolerance. Clin Transpl (2013) 0.78
Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure. Transplantation (2015) 0.77
HIV-infected kidney graft recipients managed with an early corticosteroid withdrawal protocol: clinical outcomes and messenger RNA profiles. Transplantation (2013) 0.76
Pancreas transplantation considering the spectrum of body mass indices. Clin Transplant (2011) 0.76
Living donor kidney paired donation transplantation: experience as a founding member center of the National Kidney Registry. Clin Transplant (2012) 0.76
Urinary-cell mRNA and acute kidney-transplant rejection. N Engl J Med (2013) 0.75
Transplantation: Pump it up: conserving a precious resource? Nat Rev Nephrol (2009) 0.75
Should hepatitis C virus infection be a contraindication to renal transplantation? Nat Clin Pract Nephrol (2008) 0.75
Excretion of anti-angiogenic proteins in patients with chronic allograft dysfunction. Nephrol Dial Transplant (2012) 0.75
Pancreas transplantation: does age increase morbidity? J Transplant (2011) 0.75
Noninvasive diagnosis of BK virus nephritis by measurement of messenger RNA for BK VP1 virus in urine. Transplantation (2003) 0.75
Transplantation: a report of progress. Transplantation (2010) 0.75
Renal allograft outcomes following early corticosteroid withdrawal in Hispanic transplant recipients. Clin Transplant (2013) 0.75
Managing the atazanavir-tacrolimus drug interaction in a renal transplant recipient. Am J Health Syst Pharm (2011) 0.75
Optimal modes and targets of gene therapy in transplantation. Immunol Rev (2003) 0.75
Use of bortezomib for prevention and treatment of rejection in sensitized patients. Clin Transpl (2009) 0.75
Laparoendoscopic single-site nephrectomy in obese living renal donors. J Endourol (2011) 0.75
Transplantation: a report of progress. Transplantation (2008) 0.75
Kidneys from older living donors provide excellent intermediate-term outcomes after transplantation. Transplantation (2012) 0.75
The Nobel Prize-winning work of Ralph Steinman (1943-2011) and its relevance to transplantation. Transplantation (2013) 0.75
Transplantation: a report of progress. Transplantation (2013) 0.75
Mean arterial blood pressure while awaiting kidney transplantation is associated with the risk of primary nonfunction. Transplantation (2012) 0.75